Sign in

CIK 0001763950

  • Non-accelerated filer
  • Smaller reporting company

Lantern Pharma Inc.

Sign in to watch
Ticker
LTRN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TX
Entity type
Operating
EIN
463973463
Phone
+1 972-277-1136
Business address
1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS, TX, 75201
Former names
Lantern Pharma
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-01-09 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2026-01-09 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +17,307 17,307
2024-07-15 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2024-07-15 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2021-11-04 Silberstein David S. Director Returned to the company · Stock Option (Right to Buy) −3,200 0
2021-11-04 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +3,200 3,200
2021-11-04 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +3,200 3,200
2020-06-15 Silberstein David S. Director Returned to the company · Stock Option (Right to Buy) −9,135 0
2020-06-15 Silberstein David S. Director Grant or award · Stock Option (Right to Buy) +9,135 9,135
2020-06-15 Silberstein David S. Director Grant or award · Stock Option +9,135 9,135

Page 1 of 1 · 10 trades